Showing results (81-90 of 196) with videos related to
Sort By:
Pageof 20
Cancer Innovation|July 1, 2024
MAPK4 facilitates angiogenesis by inhibiting the ERK pathway in non-small cell lung cancerJing Chen, Jing Yang, Yufang Liu, et al.Cancer Innovation|July 1, 2024
Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancerYuan-Yuan Sun, Hai-Cheng Gao, Peng Guo, et al.Cancer Innovation|July 1, 2024
Integrative genomic and transcriptomic profiling of pulmonary sarcomatoid carcinoma identifies molecular subtypes associated with distinct immune features and clinical outcomesSahil Seth, Runzhe Chen, Yang Liu, et al.Cancer Innovation|July 1, 2024
Multifaceted roles and functions of SOX30 in human cancerNa Sun, Cheng Wang, Pingping Gao, et al.Cancer Innovation|July 1, 2024
Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivoWeiran Li, Meiling Zhou, Lu Wang, et al.Cancer Innovation|July 1, 2024
A comprehensive review of 3D cancer models for drug screening and translational researchKarthikey Sharma, Sreenath Dey, Rounik Karmakar, et al.Cancer Innovation|July 1, 2024
Integrative analyses identified gap junction beta-2 as a prognostic biomarker and therapeutic target for breast cancerDi Zhang, Lixi Li, Fei MaCancer Innovation|September 11, 2024
A pan-cancer analysis of Wnt family member 7B in human cancersRui Wang, Ni-Sha Wu, Li Wang, et al.Cancer Innovation|September 20, 2024
Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2-positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatmentQiao Li, Dan Lv, Xiaoying Sun, et al.Cancer Innovation|October 25, 2024
Retinoic acid receptor responder 2 and lipid metabolic reprogramming: A new insight into brain metastasisLulu Wang, Yan GaoPageof 20